Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pulse vs Oral Cyclophosphamide in ANCA-Associated Vasculitis
NCT00430105Phase 3Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 1998
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cyclophosphamide in ANCA-associated systemic vasculitis (AAV), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Feb 1998; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
ANCA-associated systemic vasculitis (AAV)
Beyond the preview
Go deeper on NCT00430105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430105.